Phenylpiperazinylmethylheterocycle derivatives: Synthesis and dopamine receptor binding profiles

被引:8
作者
Abadi, AH [1 ]
机构
[1] Cairo Univ, Fac Pharm, Dept Pharmaceut Chem, Cairo 11562, Egypt
关键词
phenylpiperazinylmethylheterocycle derivatives; dopaminergic ligands;
D O I
10.1002/ardp.200300838
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Four series of phenylpiperazinylmethylimidazo[1,2-a]pyridine, phenylpiperazinylmethylpyrrole, phenylpiperazinylmethylbenzofuran, and phenylpiperazinylmethylbenzothiophene derivatives were synthesized and investigated for their in vitro binding profiles for the dopamine receptor subtypes D-1, D-2long, D-2short, D-3 and D-4. All tested compounds showed selectivity towards the D-4 receptor subtype. Affinity and selectivity for D-4 follows the order imidazo[1,2-a]pyridine > benzofuran > benzothiophene > pyrrole derivatives. The D-4-related affinity and selectivity pattern seems to be dependent on the presence of a region of negative molecular electrostatic potential below the heterocyclic moiety.
引用
收藏
页码:383 / 390
页数:8
相关论文
共 19 条
[1]  
*ADV CHEM DEV INC, CHEMSK 5 0 FREEW
[2]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[3]   Modified ibogaine fragments: Synthesis and preliminary pharmacological characterization of 3-ethyl-5-phenyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]benzothiophenes [J].
Efange, SMN ;
Mash, DC ;
Khare, AB ;
Ouyang, QJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (23) :4486-4491
[4]   2,2-Dicyanovinyl as a nonaromatic aryl bioisostere:: Synthesis, binding experiments and SAR studies of highly selective dopamine D4 receptor ligands [J].
Haubmann, C ;
Hübner, H ;
Gmeiner, P .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (14) :1969-1972
[5]   Cyanoindole derivatives as highly selective dopamine D4 receptor partial agonists:: Solid-phase synthesis, binding assays, and functional experiments [J].
Hübner, H ;
Kraxner, J ;
Gmeiner, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (23) :4563-4569
[6]   Conjugated enynes as nonaromatic catechol bioisosteres:: Synthesis, binding experiments, and computational studies of novel dopamine receptor agonists recognizing preferentially the D3 subtype [J].
Hübner, H ;
Haubmann, C ;
Utz, W ;
Gmeiner, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (04) :756-762
[7]  
*HYP INC, HYP 6 0
[8]  
Kraxner J, 2000, ARCH PHARM, V333, P287, DOI 10.1002/1521-4184(20009)333:9<287::AID-ARDP287>3.3.CO
[9]  
2-I
[10]   3-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]-1H-pyrrolo[2,3-b]pyridine: An antagonist with high affinity and selectivity for the human dopamine D-4 receptor [J].
Kulagowski, JJ ;
Broughton, HB ;
Curtis, NR ;
Mawer, IM ;
Ridgill, MP ;
Baker, R ;
Emms, F ;
Freedman, SB ;
Marwood, R ;
Patel, S ;
Patel, S ;
Ragan, CI ;
Leeson, PD .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (10) :1941-1942